Tag Archives: David Gryska

A Director at PDL BioPharma (NASDAQ: PDLI) is Selling Shares

On November 19, a Director at PDL BioPharma (PDLI – Research Report), David Gryska, sold shares of PDLI for $359.5K. See today’s analyst top recommended stocks >> The company has a one-year high of $3.86 and a one-year low of